Kimball Electronics Reports Q3 Results and Reiterates Guidance for Fiscal 2025 With Sales and Operating Income Expected at High-End of Range; Company Adds New Facility to Support Strategy to Drive Growth in the Medical CMO
Third Quarter Fiscal 2025 Highlights
-
Net sales totaled
$374.6 million -
Operating income of
$11.7 million , or 3.1% of net sales, adjusted operating income of 4.2% -
Inventory of
$296.6 million , a reduction of$9.6 million from Q2 -
Cash generated by operating activities of
$30.9 million , the fifth consecutive quarter of positive cash flow -
Borrowings on credit facilities of
$178.8 million , a$26.2 million decrease from the second quarter, and down$116 million , or 40%, in the fiscal year
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250506973868/en/
|
|
|
|
|
|
|
|
|
||||||||
|
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||
|
|
|
|
|
||||||||||||
|
(Amounts in Thousands, except EPS) |
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
|
|
$ |
374,607 |
|
|
$ |
425,036 |
|
|
$ |
1,106,255 |
|
|
$ |
1,284,352 |
|
|
Operating Income |
$ |
11,716 |
|
|
$ |
(6,431 |
) |
|
$ |
29,061 |
|
|
$ |
29,669 |
|
|
Adjusted Operating Income (non-GAAP) (1) |
$ |
15,706 |
|
|
$ |
18,733 |
|
|
$ |
41,629 |
|
|
$ |
58,802 |
|
|
Operating Income % |
|
3.1 |
% |
|
|
(1.5 |
)% |
|
|
2.6 |
% |
|
|
2.3 |
% |
|
Adjusted Operating Income (non-GAAP) % |
|
4.2 |
% |
|
|
4.4 |
% |
|
|
3.8 |
% |
|
|
4.6 |
% |
|
Net Income |
$ |
3,817 |
|
|
$ |
(6,076 |
) |
|
$ |
10,403 |
|
|
$ |
12,968 |
|
|
Adjusted Net Income (non-GAAP) (1) |
$ |
6,837 |
|
|
$ |
9,786 |
|
|
$ |
19,718 |
|
|
$ |
31,607 |
|
|
Diluted EPS |
$ |
0.15 |
|
|
$ |
(0.24 |
) |
|
$ |
0.41 |
|
|
$ |
0.51 |
|
|
Adjusted Diluted EPS (non-GAAP) (1) |
$ |
0.27 |
|
|
$ |
0.39 |
|
|
$ |
0.79 |
|
|
$ |
1.25 |
|
|
(1) |
Beginning in the first quarter of fiscal year 2025, adjusted results exclude stock compensation expense. Prior reported periods have been revised accordingly. A reconciliation of GAAP and non-GAAP financial measures is included below. |
Commenting on today’s announcement,
The Company ended the third quarter of fiscal 2025 with cash and cash equivalents of
|
|
Three Months Ended |
|
|
|
Nine Months Ended |
|
|
||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
|
(Amounts in Millions) |
|
2025 |
|
* |
|
|
2024 |
|
* |
|
Percent Change |
|
|
2025 |
|
* |
|
|
2024 |
|
* |
|
Percent Change |
||||||
|
Automotive |
$ |
173.1 |
|
46 |
% |
|
$ |
202.0 |
|
47 |
% |
|
(14 |
)% |
|
$ |
554.3 |
|
50 |
% |
|
$ |
614.7 |
|
48 |
% |
|
(10 |
)% |
|
Medical |
|
115.2 |
|
31 |
% |
|
|
113.0 |
|
27 |
% |
|
2 |
% |
|
|
288.9 |
|
26 |
% |
|
|
323.5 |
|
25 |
% |
|
(11 |
)% |
|
Industrial excluding AT&M (1) |
|
86.3 |
|
23 |
% |
|
|
101.9 |
|
24 |
% |
|
(15 |
)% |
|
|
261.0 |
|
24 |
% |
|
|
315.3 |
|
25 |
% |
|
(17 |
)% |
|
|
$ |
374.6 |
|
100 |
% |
$ |
416.9 |
|
98 |
% |
|
(10 |
)% |
|
$ |
1,104.2 |
|
100 |
% |
|
$ |
1,253.5 |
|
98 |
% |
|
(12 |
)% |
|
|
AT&M (1) |
|
— |
|
— |
% |
|
|
8.1 |
|
2 |
% |
|
(100 |
)% |
|
|
2.1 |
|
— |
% |
|
|
30.9 |
|
2 |
% |
|
(93 |
)% |
|
Total |
$ |
374.6 |
|
100 |
% |
|
$ |
425.0 |
|
100 |
% |
|
(12 |
)% |
|
$ |
1,106.3 |
|
100 |
% |
|
$ |
1,284.4 |
|
100 |
% |
|
(14 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
* As a percent of Total |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
(1) Sales from our Automation, |
|||||||||||||||||||||||||||||
|
– Automotive includes electronic power steering, body controls, automated driver assist systems, and electronic braking systems |
|||||||||||||||||||||||||||||
|
– Medical includes sleep therapy and respiratory care, image guided therapy, in vitro diagnostics, drug delivery, AED, and patient monitoring |
|||||||||||||||||||||||||||||
|
– Industrial includes climate controls, automation controls, and public safety |
|||||||||||||||||||||||||||||
Company Guidance for Fiscal Year 2025
The Company expects to be at the high-end of its guidance range for both net sales and adjusted operating income. The range for net sales is
|
(a) |
Fiscal year 2025 guidance reflects a change in our adjusted operating income calculation beginning in fiscal year 2025, which excludes stock compensation expense. This change better aligns our presentation with others in our industry. A reconciliation of GAAP and non-GAAP financial measures is included below. |
Forward-Looking Statements
Certain statements contained within this release are considered forward-looking, including our guidance, under the Private Securities Litigation Reform Act of 1995. The statements may be identified by the use of words such as “expect,” “should,” “goal,” “predict,” “will,” “future,” “optimistic,” “confident,” and “believe.” Undue reliance should not be placed on these forward-looking statements. These statements are based on current expectations of future events and thus are inherently subject to uncertainty. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from our expectations and projections. These forward-looking statements are subject to risks and uncertainties including, without limitation, global economic conditions, geopolitical environment and conflicts such as the war in
Non-GAAP Financial Measures
This press release contains non-GAAP financial measures. The non-GAAP financial measures contained herein include constant currency growth, net sales excluding Automation,
About
To learn more about
|
Conference Call / Webcast |
|||
|
|
|
|
|
|
|
Date: |
|
|
|
|
Time: |
|
|
|
|
Live Webcast: |
|
investors.kimballelectronics.com/events-and-presentations/events |
|
|
Dial-In #: |
|
877-407-8293 (or 201-689-8349) |
|
|
|
|
|
|
|
For those unable to participate in the live webcast, the call will be archived at investors.kimballelectronics.com. |
||
Lasting relationships. Global success.
Financial highlights for the third quarter and year-to-date period ended
|
Condensed Consolidated Statements of Income |
|
|
|
|
|
|
|||||||
|
(Unaudited) |
Three Months Ended |
||||||||||||
|
(Amounts in Thousands, except Per Share Data) |
|
|
|
||||||||||
|
|
$ |
374,607 |
|
|
100.0 |
% |
|
$ |
425,036 |
|
|
100.0 |
% |
|
Cost of Sales |
|
347,711 |
|
|
92.8 |
% |
|
|
391,492 |
|
|
92.1 |
% |
|
Gross Profit |
|
26,896 |
|
|
7.2 |
% |
|
|
33,544 |
|
|
7.9 |
% |
|
Selling and Administrative Expenses |
|
13,154 |
|
|
3.6 |
% |
|
|
16,861 |
|
|
3.9 |
% |
|
Other General Expense (Income) |
|
— |
|
|
— |
% |
|
|
(892 |
) |
|
(0.2 |
)% |
|
Restructuring Expense |
|
2,026 |
|
|
0.5 |
% |
|
|
1,622 |
|
|
0.4 |
% |
|
Goodwill Impairment |
|
— |
|
|
— |
% |
|
|
5,820 |
|
|
1.4 |
% |
|
Asset Impairment (Gain on Disposal) |
|
— |
|
|
— |
% |
|
|
16,564 |
|
|
3.9 |
% |
|
Operating Income |
|
11,716 |
|
|
3.1 |
% |
|
|
(6,431 |
) |
|
(1.5 |
)% |
|
Interest Income |
|
100 |
|
|
— |
% |
|
|
83 |
|
|
— |
% |
|
Interest Expense |
|
(2,936 |
) |
|
(0.8 |
)% |
|
|
(5,875 |
) |
|
(1.4 |
)% |
|
Non-Operating Income (Expense), net |
|
(1,726 |
) |
|
(0.4 |
)% |
|
|
(530 |
) |
|
(0.1 |
)% |
|
Other Income (Expense), net |
|
(4,562 |
) |
|
(1.2 |
)% |
|
|
(6,322 |
) |
|
(1.5 |
)% |
|
Income Before Taxes on Income |
|
7,154 |
|
|
1.9 |
% |
|
|
(12,753 |
) |
|
(3.0 |
)% |
|
Provision (Benefit) for Income Taxes |
|
3,337 |
|
|
0.9 |
% |
|
|
(6,677 |
) |
|
(1.6 |
)% |
|
Net Income (Loss) |
$ |
3,817 |
|
|
1.0 |
% |
|
$ |
(6,076 |
) |
|
(1.4 |
)% |
|
|
|
|
|
|
|
|
|
||||||
|
Earnings Per Share of Common Stock: |
|
|
|
|
|
|
|
||||||
|
Basic |
$ |
0.15 |
|
|
|
|
$ |
(0.24 |
) |
|
|
||
|
Diluted |
$ |
0.15 |
|
|
|
|
$ |
(0.24 |
) |
|
|
||
|
Average Number of Shares Outstanding: |
|
|
|
|
|
|
|
||||||
|
Basic |
|
24,728 |
|
|
|
|
|
25,118 |
|
|
|
||
|
Diluted |
|
24,872 |
|
|
|
|
|
25,118 |
|
|
|
||
|
|
|
|
|
|
|
|
|
||||||
|
(Unaudited) |
Nine Months Ended |
||||||||||||
|
(Amounts in Thousands, except Per Share Data) |
|
|
|
||||||||||
|
|
$ |
1,106,255 |
|
|
100.0 |
% |
|
$ |
1,284,352 |
|
|
100.0 |
% |
|
Cost of Sales |
|
1,032,332 |
|
|
93.3 |
% |
|
|
1,180,833 |
|
|
91.9 |
% |
|
Gross Profit |
|
73,923 |
|
|
6.7 |
% |
|
|
103,519 |
|
|
8.1 |
% |
|
Selling and Administrative Expenses |
|
37,107 |
|
|
3.4 |
% |
|
|
50,736 |
|
|
4.0 |
% |
|
Other General Expense (Income) |
|
— |
|
|
— |
% |
|
|
(892 |
) |
|
(0.1 |
)% |
|
Restructuring Expense |
|
9,019 |
|
|
0.8 |
% |
|
|
1,622 |
|
|
0.1 |
% |
|
Goodwill Impairment |
|
— |
|
|
— |
% |
|
|
5,820 |
|
|
0.5 |
% |
|
Asset Impairment (Gain on Disposal) |
|
(1,264 |
) |
|
(0.1 |
)% |
|
|
16,564 |
|
|
1.3 |
% |
|
Operating Income |
|
29,061 |
|
|
2.6 |
% |
|
|
29,669 |
|
|
2.3 |
% |
|
Interest Income |
|
575 |
|
|
0.1 |
% |
|
|
483 |
|
|
— |
% |
|
Interest Expense |
|
(11,969 |
) |
|
(1.1 |
)% |
|
|
(17,459 |
) |
|
(1.4 |
)% |
|
Non-Operating Income (Expense), net |
|
(4,155 |
) |
|
(0.4 |
)% |
|
|
(959 |
) |
|
— |
% |
|
Other Income (Expense), net |
|
(15,549 |
) |
|
(1.4 |
)% |
|
|
(17,935 |
) |
|
(1.4 |
)% |
|
Income Before Taxes on Income |
|
13,512 |
|
|
1.2 |
% |
|
|
11,734 |
|
|
0.9 |
% |
|
Provision (Benefit) for Income Taxes |
|
3,109 |
|
|
0.3 |
% |
|
|
(1,234 |
) |
|
(0.1 |
)% |
|
Net Income |
$ |
10,403 |
|
|
0.9 |
% |
|
$ |
12,968 |
|
|
1.0 |
% |
|
|
|
|
|
|
|
|
|
||||||
|
Earnings Per Share of Common Stock: |
|
|
|
|
|
|
|
||||||
|
Basic |
$ |
0.42 |
|
|
|
|
$ |
0.52 |
|
|
|
||
|
Diluted |
$ |
0.41 |
|
|
|
|
$ |
0.51 |
|
|
|
||
|
|
|
|
|
|
|
|
|
||||||
|
Average Number of Shares Outstanding: |
|
|
|
|
|
|
|
||||||
|
Basic |
|
24,859 |
|
|
|
|
|
25,084 |
|
|
|
||
|
Diluted |
|
25,047 |
|
|
|
|
|
25,263 |
|
|
|
||
| Condensed Consolidated Statements of Cash Flows |
Nine Months Ended |
||||||
|
(Unaudited) |
|
||||||
|
(Amounts in Thousands) |
|
2025 |
|
|
|
2024 |
|
|
|
$ |
105,870 |
|
|
$ |
24,717 |
|
|
|
|
(5,160 |
) |
|
|
(37,702 |
) |
|
|
|
(126,615 |
) |
|
|
36,571 |
|
|
Effect of Exchange Rate Change on Cash, Cash Equivalents, and Restricted Cash |
|
13 |
|
|
|
(113 |
) |
|
Net (Decrease) Increase in Cash, Cash Equivalents, and Restricted Cash |
|
(25,892 |
) |
|
|
23,473 |
|
|
Cash, Cash Equivalents, and Restricted Cash at Beginning of Period |
|
78,779 |
|
|
|
43,864 |
|
|
Cash, Cash Equivalents, and Restricted Cash at End of Period |
$ |
52,887 |
|
|
$ |
67,337 |
|
|
(Unaudited) |
|
|
|||
|
Condensed Consolidated Balance Sheets |
|
|
|
||
|
(Amounts in Thousands) |
|||||
|
ASSETS |
|
|
|
||
|
Cash and cash equivalents |
$ |
51,377 |
|
$ |
77,965 |
|
Receivables, net |
|
251,138 |
|
|
282,336 |
|
Contract assets |
|
78,378 |
|
|
76,320 |
|
Inventories |
|
296,602 |
|
|
338,116 |
|
Prepaid expenses and other current assets |
|
29,808 |
|
|
44,682 |
|
Assets held for sale |
|
— |
|
|
27,587 |
|
Property and Equipment, net |
|
268,351 |
|
|
269,659 |
|
|
|
6,191 |
|
|
6,191 |
|
Other Intangible Assets, net |
|
2,601 |
|
|
2,994 |
|
Other Assets, net |
|
90,109 |
|
|
82,069 |
|
Total Assets |
$ |
1,074,555 |
|
$ |
1,207,919 |
|
|
|
|
|
||
|
LIABILITIES AND SHARE OWNERS’ EQUITY |
|
|
|
||
|
Current portion of long-term debt |
$ |
28,900 |
|
$ |
59,837 |
|
Accounts payable |
|
215,430 |
|
|
213,551 |
|
Advances from customers |
|
39,676 |
|
|
30,151 |
|
Accrued expenses |
|
46,951 |
|
|
63,189 |
|
Liabilities held for sale |
|
— |
|
|
8,594 |
|
Long-term debt, less current portion |
|
149,376 |
|
|
235,000 |
|
Long-term income taxes payable |
|
— |
|
|
3,255 |
|
Other long-term liabilities |
|
46,107 |
|
|
53,881 |
|
Share Owners’ Equity |
|
548,115 |
|
|
540,461 |
|
Total Liabilities and Share Owners’ Equity |
$ |
1,074,555 |
|
$ |
1,207,919 |
|
Other Financial Metrics |
|
|
|
|
||||
|
(Unaudited) |
|
|
|
|
|
|||
|
(Amounts in Millions, except CCD) |
|
|
|
|
|
|||
|
|
At or For the |
|||||||
|
|
Three Months Ended |
|||||||
|
|
|
|
|
|
|
|||
|
|
|
2025 |
|
|
2024 |
|
|
2024 |
|
Depreciation and Amortization |
$ |
9.2 |
|
$ |
9.1 |
|
$ |
10.5 |
|
Cash Conversion Days (CCD) (1) |
|
99 |
|
|
107 |
|
|
110 |
|
Open Orders (2) |
$ |
642 |
|
$ |
564 |
|
$ |
831 |
|
(1) |
Cash Conversion Days (“CCD”) are calculated as the sum of Days Sales Outstanding plus Contract Asset Days plus Production Days Supply on Hand less Accounts Payable Days and less Advances from Customers Days. CCD, or a similar metric, is used in our industry and by our management to measure the efficiency of managing working capital. |
|
|
(2) |
Open Orders are the aggregate sales price of production pursuant to unfulfilled customer orders. Our declining open orders are primarily due to the cancellation of a major automotive program and other demand reductions, as well as reduced lead times on customer orders as compared to |
|
Select Financial Results of Automation, |
|
|
|
|
|||||||||
|
(Unaudited) |
|
|
|
|
|
|
|
||||||
|
(Amounts in Millions) |
|
|
|
|
|
|
|
||||||
|
|
Three Months Ended |
|
Nine Months Ended |
||||||||||
|
|
|
|
|
||||||||||
|
|
|
2025 |
|
|
2024 |
|
|
|
2025 |
|
|
2024 |
|
|
|
$ |
— |
|
$ |
8.1 |
|
|
$ |
2.1 |
|
$ |
30.9 |
|
|
Operating Income (Loss) (1) |
$ |
— |
|
$ |
(25.4 |
) |
|
$ |
0.8 |
|
$ |
(24.3 |
) |
|
(1) |
Includes gain on sale of |
|
Reconciliation of Non-GAAP Financial Measures |
|
|
|
|
|
|
|
||||||||
|
(Unaudited, Amounts in Thousands, except Per Share Data) |
|
|
|
|
|
|
|
||||||||
|
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||
|
|
|
|
|
||||||||||||
|
|
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
|
Net Sales Growth (vs. same period in prior year) |
|
(12 |
)% |
|
|
(12 |
)% |
|
|
(14 |
)% |
|
|
(3 |
)% |
|
Foreign Currency Exchange Impact |
|
(1 |
)% |
|
|
— |
% |
|
|
— |
% |
|
|
— |
% |
|
Constant Currency Growth |
|
(11 |
)% |
|
|
(12 |
)% |
|
|
(14 |
)% |
|
|
(3 |
)% |
|
|
|
|
|
|
|
|
|
||||||||
|
Selling and Administrative Expenses, as reported |
$ |
13,154 |
|
|
$ |
16,861 |
|
|
$ |
37,107 |
|
|
$ |
50,736 |
|
|
Stock Compensation Expense |
|
(1,955 |
) |
|
|
(1,773 |
) |
|
|
(4,528 |
) |
|
|
(5,435 |
) |
|
SERP |
|
(9 |
) |
|
|
(277 |
) |
|
|
(285 |
) |
|
|
(584 |
) |
|
Adjusted Selling and Administrative Expenses |
$ |
11,190 |
|
|
$ |
14,811 |
|
|
$ |
32,294 |
|
|
$ |
44,717 |
|
|
|
|
|
|
|
|
|
|
||||||||
|
Operating Income (Loss), as reported |
$ |
11,716 |
|
|
$ |
(6,431 |
) |
|
$ |
29,061 |
|
|
$ |
29,669 |
|
|
Stock Compensation Expense |
|
1,955 |
|
|
|
1,773 |
|
|
|
4,528 |
|
|
|
5,435 |
|
|
SERP |
|
9 |
|
|
|
277 |
|
|
|
285 |
|
|
|
584 |
|
|
Legal Settlements (Recovery) |
|
— |
|
|
|
(892 |
) |
|
|
— |
|
|
|
(892 |
) |
|
Restructuring Expense |
|
2,026 |
|
|
|
1,622 |
|
|
|
9,019 |
|
|
|
1,622 |
|
|
Goodwill Impairment |
|
— |
|
|
|
5,820 |
|
|
|
— |
|
|
|
5,820 |
|
|
Asset Impairment (Gain on Disposal) |
|
— |
|
|
|
16,564 |
|
|
|
(1,264 |
) |
|
|
16,564 |
|
|
Adjusted Operating Income |
$ |
15,706 |
|
|
$ |
18,733 |
|
|
$ |
41,629 |
|
|
$ |
58,802 |
|
|
|
|
|
|
|
|
|
|
||||||||
|
Net Income (Loss), as reported |
$ |
3,817 |
|
|
$ |
(6,076 |
) |
|
$ |
10,403 |
|
|
$ |
12,968 |
|
|
Stock Compensation Expense, After-Tax |
|
1,483 |
|
|
|
1,345 |
|
|
|
3,434 |
|
|
|
4,122 |
|
|
Legal Settlements (Recovery), After-Tax |
|
— |
|
|
|
(676 |
) |
|
|
— |
|
|
|
(676 |
) |
|
Restructuring Expense, After-Tax |
|
1,537 |
|
|
|
1,230 |
|
|
|
6,840 |
|
|
|
1,230 |
|
|
Goodwill Impairment, After-Tax |
|
— |
|
|
|
4,414 |
|
|
|
— |
|
|
|
4,414 |
|
|
Asset Impairment (Gain on Disposal), After-Tax |
|
— |
|
|
|
9,549 |
|
|
|
(959 |
) |
|
|
9,549 |
|
|
Adjusted Net Income |
$ |
6,837 |
|
|
$ |
9,786 |
|
|
$ |
19,718 |
|
|
$ |
31,607 |
|
|
|
|
|
|
|
|
|
|
||||||||
|
Diluted Earnings per Share, as reported |
$ |
0.15 |
|
|
$ |
(0.24 |
) |
|
$ |
0.41 |
|
|
$ |
0.51 |
|
|
Stock Compensation Expense |
|
0.06 |
|
|
|
0.05 |
|
|
|
0.14 |
|
|
|
0.16 |
|
|
Legal Settlements (Recovery) |
|
— |
|
|
|
(0.03 |
) |
|
|
— |
|
|
|
(0.03 |
) |
|
Restructuring Expense |
|
0.06 |
|
|
|
0.05 |
|
|
|
0.27 |
|
|
|
0.05 |
|
|
Goodwill Impairment |
|
— |
|
|
|
0.18 |
|
|
|
— |
|
|
|
0.18 |
|
|
Asset Impairment (Gain on Disposal) |
|
— |
|
|
|
0.38 |
|
|
|
(0.03 |
) |
|
|
0.38 |
|
|
Adjusted Diluted Earnings per Share |
$ |
0.27 |
|
|
$ |
0.39 |
|
|
$ |
0.79 |
|
|
$ |
1.25 |
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
Twelve Months Ended |
|
|
|
|
||||||||||
|
|
|
|
|
|
|
||||||||||
|
|
|
2025 |
|
|
|
2024 |
|
|
|
|
|
||||
|
Operating Income |
$ |
48,669 |
|
|
$ |
61,118 |
|
|
|
|
|
||||
|
Goodwill Impairment |
|
— |
|
|
|
5,820 |
|
|
|
|
|
||||
|
SERP |
|
381 |
|
|
|
827 |
|
|
|
|
|
||||
|
Restructuring Expense |
|
9,783 |
|
|
|
1,622 |
|
|
|
|
|
||||
|
Asset Impairment (Gain on Disposal) |
|
(788 |
) |
|
|
16,564 |
|
|
|
|
|
||||
|
Legal Settlements (Recovery) |
|
— |
|
|
|
(1,104 |
) |
|
|
|
|
||||
|
Stock Compensation Expense |
|
6,278 |
|
|
|
6,992 |
|
|
|
|
|
||||
|
Adjusted Operating Income (non-GAAP) |
$ |
64,323 |
|
|
$ |
91,839 |
|
|
|
|
|
||||
|
Tax Effect |
|
20,174 |
|
|
|
21,698 |
|
|
|
|
|
||||
|
After-tax Adjusted Operating Income |
$ |
44,149 |
|
|
$ |
70,141 |
|
|
|
|
|
||||
|
|
$ |
726,208 |
|
|
$ |
783,059 |
|
|
|
|
|
||||
|
ROIC |
|
6.1 |
% |
|
|
9.0 |
% |
|
|
|
|
||||
|
(1) |
Average invested capital is computed using Share Owners’ equity plus current and non-current debt less cash and cash equivalents averaged for the last five quarters. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20250506973868/en/
Treasurer and Investor Relations Officer
812.827.4151
Investor.Relations@kimballelectronics.com
Source:
